SCHEMBL169807

SCHEMBL169807

O=C(O)CC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6251607 0.96
SCHEMBL5212661 0.85
Malonic Acid SCHEMBL29116689 0.80 LDHA (0.75)
SCHEMBL125404 0.79
Malonic Acid SCHEMBL6923127 0.77 LDHA (0.69)
Ammonia Solution, Strong SCHEMBL27404985 0.75
Malonic Acid SCHEMBL1332554 0.74
Malonic Acid SCHEMBL336 0.74
Malonic Acid SCHEMBL1332405 0.74
Malonic Acid SCHEMBL23831 0.74 LDHA (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596054-B1 5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS FONDAZIONE ST ITALIANO TECNOLOGIA (IT) 2021-01-27 EP claimed
EP-2943468-B1 A NOVEL PROCESS FOR THE PREPARATION OF N-(4-NITRO-2-SULFAMOYL-PHENYL)-MALONAMIC ACID METHYL ESTER AND N-(4-AMINO-2-SULFAMOYL-PHENYL)-MALONAMIC ACID METHYL ESTER HOFFMANN LA ROCHE (CH) 2017-03-01 EP claimed
CN-104961758-A Chain musk odorant and preparation method thereof ZHENGZHOU TOBACCO RES CNTC 2015-10-07 CN claimed
EP-0367131-B1 Light-sensitive composition BASF AG (DE) 1995-02-22 EP claimed
EP-4735431-A2 MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2026-05-06 EP disclosed
WO-2025006568-A2 MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2025-01-02 WO disclosed
US-20240409556-A1 BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. 2024-12-12 US disclosed
EP-4402126-A1 AHR AGONISTS Eli Lilly and Company (US) 2024-07-24 EP disclosed
US-12037322-B2 AHR agonists ELI LILLY AND COMPANY (US) 2024-07-16 US disclosed
CN-118215654-A AHR agonists 伊莱利利公司 2024-06-18 CN disclosed
US-11912714-B2 Spiropyrrolidine derived antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2024-02-27 US disclosed
CN-111032643-B Quinolinone compounds 詹森药业有限公司 2023-05-30 CN disclosed
EP-0082712-A2 2-Phenylimidazo(2,1-b)benzothiazole compounds, salts thereof, process for producing them, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1983-06-29 EP disclosed
EP-0072743-A1 1,2-Dithiol-3-ylidene ammonium derivatives, process for their preparation and medicines containing them RHONE-POULENC SANTE (FR) 1983-02-23 EP disclosed
EP-0063509-A1 2-Piperazino-pyrimidine derivatives, processes for their preparation, medicaments containing them and their use as intermediates in the manufacture of medicaments PHARMUKA LABORATOIRES (FR) 1982-10-27 EP disclosed
US-4336380-A FOR USE AS HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1982-06-22 US disclosed
US-4296236-A ANTIBIOTICS MERCK & CO., INC. (US) 1981-10-20 US disclosed
US-4278793-A ANTIBIOTICS, BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed
US-4276417-A TREATMENT OF VASCULAR-CONDITION HYPERTENSION HOFFMANN-LA ROCHE INC. (US) 1981-06-30 US disclosed
US-3965118-A Lactone intermediates THE UPJOHN COMPANY (US) 1976-06-22 US disclosed